Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page
- CheckyesterdayChange DetectedThe page footer revision number was updated from v3.5.2 to v3.5.3, indicating a non-content site/version change.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision metadata updated to v3.5.0. The previous revision v3.4.3 was removed from the history.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision tag updated to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedThe update adds Revision: v3.4.2 and removes the earlier government-funding notice (v3.4.1), a minor maintenance update to the page.SummaryDifference0.5%

- Check80 days agoChange DetectedA government-funding lapse notice was added, directing users to cc.nih.gov and opm.gov for updates. A new Revision: v3.4.1 banner replaces the previous v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.